A practical reference on pentadecapeptide: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
BPC-157 is a synthetic pentadecapeptide whose sequence is commonly given as Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is described in the literature as a fragment of a larger protein found in human gastric juice, referred to as body protection compound. The peptide was first characterized in the early 1990s by a research group in Zagreb, Croatia. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Supplied material is typically a lyophilized white to off-white powder. The peptide is freely soluble in water and in common aqueous buffers, which allows it to be handled as a stock solution. Because the sequence contains no cysteine, disulfide cross-linking is not a route of degradation. The absence of aromatic residues means ultraviolet absorbance at 280 nm is minimal, so quantification usually relies on peptide bond absorbance near 214 nm or on amino acid analysis.
Lyophilized material is generally kept cold, commonly at minus twenty degrees Celsius, and shielded from moisture and light. Solutions are less stable than the dry powder, so repeated freeze-thaw cycles are avoided by splitting the material into single-use portions. Published stability data for this particular peptide are limited, which means suggested hold times should be read as provisional. Long-term refrigeration of reconstituted solutions is not well supported by available evidence.
Identity and purity are checked with standard peptide techniques. Reversed-phase high-performance liquid chromatography separates the main peak from closely related impurities and yields a percentage purity. Mass spectrometry confirms that the measured mass matches the theoretical value. Amino acid analysis offers an independent check on overall composition. These analytical methods characterize the material itself and reveal nothing about how it behaves in a living system.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white lyophilized powder | Assessed by visual inspection under ordinary laboratory lighting |
| Molecular mass | Approximately 1419 Da | Monoisotopic mass for the fifteen-residue sequence |
| Solubility class | Freely soluble in water | Stock solutions commonly prepared in water or aqueous buffer |
| Typical storage temperature | -20 °C or below, desiccated | Lyophilized powder; repeated freeze-thaw cycles are usually avoided |
| Common analytical method | Reversed-phase HPLC with UV detection | Frequently paired with mass spectrometry to confirm identity |
BPC-157 is commonly supplied as a lyophilized powder, a freeze-dried solid that is reconstituted before use in laboratory work. As a short peptide, it dissolves readily in water and in aqueous buffer solutions, and stock solutions are typically prepared in water or a mild buffer. The chain contains several proline and acidic residues, which influence how it behaves in solution. Because the solid can take up moisture, weighing and handling are usually performed under low-humidity conditions. Its solubility class is described as freely soluble in water rather than requiring an organic solvent.
Dry powder is generally stored at low temperature, with minus twenty degrees Celsius or colder advised for extended retention. Reconstituted solutions are less stable than the solid form and are normally kept cold and shielded from repeated freeze-thaw cycles. Light exposure is avoided because some peptides degrade under ultraviolet radiation. The exact rate of degradation depends on concentration, pH, and the presence of salts, so a single shelf life does not apply to every preparation. Reported stability figures should be read as indicative of typical handling rather than as universal constants.
Confirmation of identity and purity relies on standard peptide analysis techniques. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities and serves as the most common purity assay. Mass spectrometry, often coupled to that chromatography step, provides an accurate molecular mass that can be matched against the expected value. Amino acid analysis or sequencing can be added for further confirmation. Because short peptides can be produced by different synthetic routes, laboratories usually report both a chromatographic purity percentage and a mass confirmation rather than a single figure.
Identity and purity are established using reversed-phase high-performance liquid chromatography, which separates the peptide from related impurities and yields a percentage purity. Mass spectrometry, typically with electrospray ionization, confirms the molecular mass against the expected value. Amino acid analysis or peptide mapping provides additional sequence confirmation. These methods are complementary, since chromatography measures how much material is present while mass spectrometry verifies what that material is. A certificate of analysis normally reports both.
Analytical results depend on the column, gradient, and detector wavelength chosen by the laboratory, so purity values from different sources are not always directly comparable. Water content, counterion form, and residual trifluoroacetate affect both mass and purity calculations. Microbiological and endotoxin testing are separate from chemical purity and are not covered by a standard chromatographic run. Buyers evaluating a material typically request the full method description rather than a single purity figure.
Lyophilized peptide powder is generally stored at minus twenty degrees Celsius or lower and kept away from light and moisture. Under these conditions degradation is slow, and sealed vials remain stable for extended periods. Once dissolved, the material is less stable, particularly in aqueous buffers near neutral pH, where hydrolysis and oxidation proceed faster. Solutions are usually kept cold and used within days to weeks. Repeated freeze-thaw cycles are avoided because they encourage aggregation.
=== Eruption of the fighting === 27 December 1918: The uprising starts in the evening with shooting in front of Poznań's police headquarters. Fighting also start in other towns: Szamotuły, Środa Wielkopolska, Pniewy, Opalenica, Buk, Trzemeszno, Września and Gniezno are captured. Poles in Poznań capture the main train station, the main post office and part of city fortifications. 28 December 1918: The Poles in Poznań capture Cytadela (a main stronghold), Fort Grolmann and an armory on ul. Wielkie Garbary The commission of the NRL promotes Captain Stanisław Taczak to temporary commander-in-chief of the uprising (he is also promoted to rank of major). 29 December 1918: The Poles capture Grodzisk Wielkopolski, Kłecko, Kórnik, Wielichowo, Gostyń, Witkowo and other towns. 30 December 1918 Failure of peace talks between the insurgents and the German authorities, the latter refusing to take the responsibility for the hostilities of 27 December. In Poznań, the Poles force the German 6th Regiment of Grenadiers from their barracks. After talks, the regiment leaves the city with their weapons. The Poles capture Wronki, Wągrowiec, Gołańcz. Polish soldiers stop a German offensive against Gniezno near Zdziechowa. 31 December 1918 The Poles capture Kościan, Oborniki Wielkopolskie, Ostrów Wielkopolski. A unit of Poles under command of Paweł Cyms begins offensive on Cuiavia. 1 January 1919 Paderewski leaves Poznań. The capture of Jarocin, Krotoszyn and Mogilno.
=== Drug delivery === Researchers at Monash University discovered that a sheet of graphene oxide can be transformed into liquid crystal droplets spontaneously—like a polymer—simply by placing the material in a solution and manipulating the pH. The graphene droplets change their structure in the presence of an external magnetic field. This finding raises the possibility of carrying a drug in graphene droplets and releasing the drug upon reaching the targeted tissue by making the droplets change shape in a magnetic field. Another possible application is in disease detection if graphene is found to change shape at the presence of certain disease markers such as toxins. A graphene 'flying carpet' was demonstrated to deliver two anti-cancer drugs sequentially to the lung tumor cells (A549 cell) in a mouse model. Doxorubicin (DOX) is embedded onto the graphene sheet, while the molecules of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) are linked to the nanostructure via short peptide chains. Injected intravenously, the graphene strips with the drug payload preferentially concentrate to the cancer cells due to common blood vessel leakage around the tumor. Receptors on the cancer cell membrane bind TRAIL and cell surface enzymes clip the peptide thus release the drug onto the cell surface. Without the bulky TRAIL, the graphene strips with the embedded DOX are swallowed into the cells. The intracellular acidic environment promotes DOX's release from graphene. TRAIL on the cell surface triggers the apoptosis while DOX attacks the nucleus.
Pancreatic secretory trypsin inhibitor (PSTI) also known as serine protease inhibitor Kazal-type 1 (SPINK1) or tumor-associated trypsin inhibitor (TATI) is a protein that in humans is encoded by the SPINK1 gene. In the context of rat biology, it is also sometimes called monitor peptide.
Paralogous genes can shape the structure of whole genomes and thus explain genome evolution to a large extent. Examples include the Homeobox (Hox) genes in animals. These genes not only underwent gene duplications within chromosomes but also whole genome duplications. As a result, Hox genes in most vertebrates are clustered across multiple chromosomes with the HoxA-D clusters being the best studied. Another example are the globin genes which encode myoglobin and hemoglobin and are considered to be ancient paralogs. Similarly, the four known classes of hemoglobins (hemoglobin A, hemoglobin A2, hemoglobin B, and hemoglobin F) are paralogs of each other. While each of these proteins serves the same basic function of oxygen transport, they have already diverged slightly in function: fetal hemoglobin (hemoglobin F) has a higher affinity for oxygen than adult hemoglobin. Function is not always conserved, however. Human angiogenin diverged from ribonuclease, for example, and while the two paralogs remain similar in tertiary structure, their functions within the cell are now quite different. It is often asserted that orthologs are more functionally similar than paralogs of similar divergence, but several papers have challenged this notion. In collaborative work, Anton Yuryev and co-authors demonstrated that genome-wide protein–protein interaction networks contain a significantly higher frequency of self-interacting proteins (homodimers) and interactions between paralogous proteins than would be expected by chance.
Sources: en.wikipedia.org
== Research == The first-in-human study, a phase 1 trial, was initiated in October 2017 and completed in September 2020 in postmenopausal women with breast cancer. The study investigated oral doses of vosilasarm of 50 mg/day to 150 mg/day, with the maximum tolerated dose found to be 100 mg/day. A phase 1/2 study proposal of vosilasarm for treatment of breast cancer was published in 2023. It will recruit up to 128 patients.
=== Potato Sack === The Potato Sack was an A.R.G (alternate reality game) conceived by Valve and 13 indie video game developers as a prelude to the release of Portal 2. Portal 2 had been announced by a similar game, where a patch applied to the Steam version of Portal in March 2010, provided clues heralding the official announcement. The Potato Sack game, launched on April 1, 2011, led to the reveal of "GLaDOS@home", a spoof of distributed computer challenges, to get players to cooperate on playing the independent games as to unlock Portal 2 on Steam about 10 hours before its planned release.
== Pharmacokinetics == Trelagliptin's uniquely designed structure enhances its chemical stability and resistance to metabolic degradation. It binds strongly to the DPP-4 enzyme, with a slow dissociation rate (~30 minutes), compared to sitagliptin (3.5 min) and vildagliptin (<2 min). This prolonged binding contributes to its sustained DPP-4 inhibition. Trelagliptin has a long elimination half-life of approximately 54.3 hours. A 100 mg once-weekly dose maintained 77.4% DPP-4 inhibition 7 days post-dose. The drug reaches steady-state plasma levels (20.00–21.60 ng/mL) by week 4. These properties support its effective once-weekly dosing regimen.
Sources: en.wikipedia.org
Carpipramine (Prazinil, Defekton) is an atypical antipsychotic used for the treatment of schizophrenia and anxiety in France and Japan. In addition to its neuroleptic and anxiolytic effects, carpipramine also has hypnotic properties. It is structurally related to both tricyclics like imipramine and butyrophenones like haloperidol.
=== Water packs === Water packs are flat and leak-proof plastic containers used in the interiors of cold boxes and vaccine carriers. These containers are set to the appropriate temperature depending on the type of vaccine being transported. The temperature could range from -10° to +24 °C and does not last that long before coming back to the same temperature as the surroundings.
== Drying defects == Drying defects are the most common form of degrade in timber, next to natural problems such as knots. There are two types of drying defects, although some defects involve both causes:
Overexposure to UVB radiation not only can cause sunburn but also some forms of skin cancer. However, the degree of redness and eye irritation (which are largely not caused by UVA) do not predict the long-term effects of UV, although they do mirror the direct damage of DNA by ultraviolet. All bands of UV radiation damage collagen fibers and accelerate aging of the skin, but the two bands reaching the ground act differently: UVB is largely absorbed in the epidermis and is the main cause of sunburn, while UVA penetrates deeper into the skin and is the main driver of photoaging, causing little redness, which makes exposure easy to underestimate. Both UVA and UVB destroy vitamin A in skin, which may cause further damage. UVB radiation can cause direct DNA damage. This cancer connection is one reason for concern about ozone depletion and the ozone hole. The most deadly form of skin cancer, melanoma, is mostly caused by DNA damage independent from UVA radiation. This can be seen from the absence of a direct UV signature mutation in 92% of all melanoma. Occasional overexposure and sunburn are probably greater risk factors for melanoma than long-term moderate exposure. UVC is the highest-energy, most-dangerous type of ultraviolet radiation, and causes adverse effects that can variously be mutagenic or carcinogenic. In the past, UVA was considered not harmful or less harmful than UVB, but today it is known to contribute to skin cancer via indirect DNA damage (free radicals such as reactive oxygen species).
Sources: en.wikipedia.org
It is a synthetic peptide built from fifteen amino acids, with a mass of roughly 1419 daltons. The sequence is reported to match a fragment of a protein present in human gastric juice. It is not a naturally circulating hormone.
It is normally supplied as a lyophilized powder in a sealed vial. The powder dissolves readily in water, and stock solutions are typically prepared shortly before use. Cold storage is standard laboratory practice.
The letters are generally read as shorthand for body protection compound. That label comes from the original research context rather than from formal nomenclature. No standardized nonproprietary name exists for the peptide.
Dry powder is commonly held at minus twenty degrees Celsius, desiccated and away from light. Cold storage slows degradation of the lyophilized material.